These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2117674)

  • 1. Effects of a new bisphosphonate (AHBuBP) on osteolysis induced by human prostate cancer cells in nude mice.
    Nemoto R; Sato S; Nishijima Y; Miyakawa I; Koiso K; Harada M
    J Urol; 1990 Sep; 144(3):770-4. PubMed ID: 2117674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition by a new bisphosphonate (AHBuBP) of bone resorption induced by the MBT-2 tumor of mice.
    Nemoto R; Satou S; Miyagawa I; Koiso K
    Cancer; 1991 Feb; 67(3):643-8. PubMed ID: 1898709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition by a new bisphosphonate (YM175) of bone resorption induced by the MBT-2 tumour of mice.
    Nemoto R; Nishijima Y; Uchida K; Koiso K
    Br J Cancer; 1993 May; 67(5):893-7. PubMed ID: 8494721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of four bisphosphonates on bone resorption, lysosomal enzyme release, protein synthesis and mitotic activities in mouse calvarial bones in vitro.
    Lerner UH; Larsson A
    Bone; 1987; 8(3):179-89. PubMed ID: 2955802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of MBT-2 bladder carcinoma-induced osteolysis to various agents.
    Nemoto R; Satou S; Mochizuki T; Okabe K
    Cancer; 1992 May; 69(9):2316-21. PubMed ID: 1562978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative morphometric evaluation of the inhibitory activity of new aminobisphosphonates on bone resorption in the rat.
    Schenk R; Eggli P; Fleisch H; Rosini S
    Calcif Tissue Int; 1986 Jun; 38(6):342-9. PubMed ID: 3089557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Establishment of a model to evaluate inhibition of bone resorption induced by bladder tumor (MBT-2) in mice].
    Nishijima Y; Nemoto R; Koiso K
    Nihon Hinyokika Gakkai Zasshi; 1990 May; 81(5):694-700. PubMed ID: 2376925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A model of localized osteolysis induced by the MBT-2 tumor in mice and its responsiveness to etidronate disodium.
    Nemoto R; Uchida K; Tsutsumi M; Koiso K; Satou S; Satou T
    J Cancer Res Clin Oncol; 1987; 113(6):539-43. PubMed ID: 3119600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of a model to evaluate inhibition of bone resorption induced by human prostate cancer cells in nude mice.
    Nemoto R; Kanoh S; Koiso K; Harada M
    J Urol; 1988 Oct; 140(4):875-9. PubMed ID: 3138435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of inhibitory effects by murine interferon gamma and a new bisphosphonate (alendronate) in hypercalcemic, nude mice bearing human tumor (LJC-1-JCK).
    Tohkin M; Kakudo S; Kasai H; Arita H
    Cancer Immunol Immunother; 1994 Sep; 39(3):155-60. PubMed ID: 7522963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anchorage and retentive effects of a bisphosphonate (AHBuBP) on tooth movements in rats.
    Igarashi K; Mitani H; Adachi H; Shinoda H
    Am J Orthod Dentofacial Orthop; 1994 Sep; 106(3):279-89. PubMed ID: 8074093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dichloromethylene diphosphonate on the osteolytic and osteoplastic effects of rat prostate adenocarcinoma cells.
    Pollard M; Luckert PH
    J Natl Cancer Inst; 1985 Nov; 75(5):949-54. PubMed ID: 2932588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic and migration inhibitory effects of bisphosphonates on macrophages.
    Stevenson PH; Stevenson JR
    Calcif Tissue Int; 1986 Apr; 38(4):227-33. PubMed ID: 3085901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of bone matrix apposition by (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (AHPrBP) in the mouse.
    Marie PJ; Hott M; Garba MT
    Bone; 1985; 6(3):193-200. PubMed ID: 4027097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bisphosphonates HEBP and AHPrBP but not AHBP inhibit mineral mobilization and lysosomal enzyme release from mouse calvarial bones in tissue culture.
    Lerner U; Larsson A
    Experientia; 1984 Sep; 40(9):965-7. PubMed ID: 6468624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of bisphosphonates APD and HEBP on bone metabolism in vitro.
    Goziotis A; Sukhu B; Torontali M; Dowhaniuk M; Tenenbaum HC
    Bone; 1995 Apr; 16(4 Suppl):317S-327S. PubMed ID: 7626321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of bisphosphonates on proliferation and viability of mouse bone marrow-derived macrophages.
    Cecchini MG; Felix R; Fleisch H; Cooper PH
    J Bone Miner Res; 1987 Apr; 2(2):135-42. PubMed ID: 3455162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential action of the bisphosphonates (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) and disodium dichloromethylidene bisphosphonate (Cl2MDP) on rat macrophage-mediated bone resorption in vitro.
    Reitsma PH; Teitelbaum SL; Bijvoet OL; Kahn AJ
    J Clin Invest; 1982 Nov; 70(5):927-33. PubMed ID: 7130396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition by two diphosphonates of bone lysis in tumor-conditioned media.
    Jung A; Mermillod B; Barras C; Baud M; Courvoisier B
    Cancer Res; 1981 Aug; 41(8):3233-7. PubMed ID: 6454481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrasting effects of an aminobisphosphonate, a potent inhibitor of bone resorption, on lipopolysaccharide-induced production of interleukin-1 and tumour necrosis factor alpha in mice.
    Sugawara S; Shibazaki M; Takada H; Kosugi H; Endo Y
    Br J Pharmacol; 1998 Oct; 125(4):735-40. PubMed ID: 9831909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.